Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UGCG | Q16739 | 5/20 | 0.46 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.41 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | P2RY1 | P47900 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.37 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
| ▸ | SPR | P35270 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29907559 | 1.00 | UGCG (0.46) | UGCGSCN9ANR1I2HPGDP2RY1 | |
| SCHEMBL29907661 | 0.92 | UGCG (0.47) | UGCGSCN9AHCRTR1HCRTR2KMT2A | |
| SCHEMBL29907379 | 0.91 | UGCG (0.46) | UGCGSCN9AP2RY1HCRTR1HCRTR2 | |
| SCHEMBL29907631 | 0.88 | UGCG (0.44) | UGCGSCN9AP2RY1HCRTR1HCRTR2 | |
| SCHEMBL29601829 | 0.88 | UGCG (0.59) | UGCGP2RY1HCRTR1HCRTR2 | |
| SCHEMBL29907363 | 0.85 | SCN9A (0.46) | UGCGSCN9AP2RY1HTTKMT2A | |
| SCHEMBL29907458 | 0.85 | UGCG (0.47) | UGCGSCN9AP2RY1HCRTR1HCRTR2 | |
| SCHEMBL29602191 | 0.85 | UGCG (0.46) | UGCGSCN9AHCRTR1HCRTR2 | |
| SCHEMBL29907424 | 0.83 | UGCG (0.51) | UGCGSCN9AP2RY1 | |
| SCHEMBL29907369 | 0.81 | UGCG (0.62) | UGCGSCN9AHCRTR1HCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4005637-A1 | HETEROCYCLIC COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2022-06-01 | — | — | EP | disclosed |
| EP-4005637-A1 | HETEROCYCLIC COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2022-06-01 | — | — | EP | disclosed |